Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,45 HKD | +3,76% | +25,00% | +11,53% |
15/04 | Ocumension Therapeutics kondigt fase III klinische studie van OT-502 in China aan | CI |
08/04 | Ocumension Therapeutics' oogmedicijn voltooit klinische tests en zal binnenkort een NDA aanvragen | MT |
Vakgebied
Aantal werknemers: 444
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Ophthalmic Pharmaceutical Platform
100,0
%
| 185 | 100,0 % | 272 | 100,0 % | +47,28% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 185 | 100,0 % | 272 | 100,0 % | +47,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ye Liu
CEO | Chief Executive Officer | 53 | 01-08-18 |
Tim Ruan
DFI | Director of Finance/CFO | 38 | 12-01-23 |
Dong Hong Chen
CTO | Chief Tech/Sci/R&D Officer | 53 | 28-10-19 |
Zhao Peng Hu
BRD | Director/Board Member | 51 | 03-09-18 |
Ting Chan Chen
SEC | Corporate Secretary | 30 | 01-07-21 |
Qinglei Zuo
PRN | Corporate Officer/Principal | 40 | 01-01-21 |
Hong Ying Liu
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Li
BRD | Director/Board Member | 52 | 01-04-18 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 18-06-19 |
Ting Yuk Wu
BRD | Director/Board Member | 69 | 23-06-20 |
Lian Yong Chen
CHM | Chairman | 62 | 23-05-18 |
Yumeng Wang
BRD | Director/Board Member | 33 | 19-03-21 |
Zhenyu Zhang
BRD | Director/Board Member | 50 | 08-04-22 |
Ye Liu
CEO | Chief Executive Officer | 53 | 01-08-18 |
Zhao Peng Hu
BRD | Director/Board Member | 51 | 03-09-18 |
Yi Ran Huang
BRD | Director/Board Member | 69 | 23-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 695 614 850 | 330 899 975 ( 47,57 %) | 0 | 47,57 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALIMERA SCIENCES, INC. 2.19% | 1 144 945 | 2.19% | 4 465 286 $ |
100 221 | 0.20% | 2 071 568 $ |
Bedrijfsgegevens
Ocumension Therapeutics
No. 1858 Yinzhongnan Road Guoxiang Subdistrict
215000, Suzhou
+
http://www.ocumension.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,53% | 637 mln. | |
+31,49% | 699 mld. | |
+25,07% | 571 mld. | |
-4,25% | 364 mld. | |
+18,31% | 326 mld. | |
+3,16% | 286 mld. | |
+14,55% | 236 mld. | |
+4,68% | 198 mld. | |
-12,52% | 194 mld. | |
-4,53% | 154 mld. |
- Beurs
- Aandelen
- Koers 1477
- Onderneming Ocumension Therapeutics